SYS-CON MEDIA Authors: Pat Romanski, Adrian Bridgwater, Yeshim Deniz, Elizabeth White, Sean Houghton

News Feed Item

The 15th Annual BioEquity Europe Conference Features More Than 100 Innovator Companies With Differentiated Products, Upcoming Milestones and Partner-Ready Assets

Two Days of Plenary Sessions Examine How European Companies Are Stepping Up to Play in Biotech's Premier League

REDWOOD CITY, CA -- (Marketwired) -- 05/20/14 -- BioCentury, EBD Group and the Biotechnology Industry Organization (BIO) will convene the 15th Annual BioEquity Europe conference in Amsterdam on Wednesday, May 21, and Thursday, May 22, at the Hilton Amsterdam Hotel. More than 500 life science investment professionals and pharmaceutical business development and licensing executives have registered. Walk-up registration is available at the Hilton Amsterdam Hotel starting at 7:45 a.m. on May 21.

BioEquity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects.

In 2014, the conference will showcase presentations by 68 mature and 42 newly formed innovator biopharma companies. The Presenting Companies have been hand-picked by BioCentury on the basis of investor validation, upcoming milestones and unpartnered assets. The slate of Next Wave Companies features fresh opportunities for venture capital investment and early stage partnering opportunities in the biotech space.

More than half a dozen plenaries and Q&A sessions over the two days will feature 45 key opinion leaders. These sessions will be highlighted by a fireside chat with Dr. Jordi Llinares-Garcia -- EMA's Head of Product Development Scientific Support Department and former Head of Orphan Drugs. During this session, BioCentury's Chairman & Editor-in-Chief Dr. Karen Bernstein will interview Dr. Llinares-Garcia about how the agency acts as an "enabler" for smaller players, including academia, in the pharmaceutical innovation ecosystem.

Back by popular demand is the BioCentury/Ernst & Young Face-Off. At the Face-Off, BioCentury will unveil its 12th annual "European Iceberg" report, which projects funding demands by Europe's clinical stage biotechnology companies, and Ernst & Young will provide analysis from its 28th annual "Beyond Borders Global Biotechnology Report." The Face-Off will be chaired by Susan Schaeffer, Editor of BioCentury, and Jürg Zürcher, Partner, EMEIA Biotechnology Leader, Ernst & Young.

Other plenaries will focus on how European biotechs can better compete with U.S. companies for capital, and how European science stands up against a global playing field.

"The full slate of presenting companies, distinguished faculty and strong pre-registration numbers indicate a renewed interest in European biotechs by the investment and licensing communities," said BioCentury Publisher Eric Pierce. "The compelling stories from the Class of 2014, coupled with high-impact discussions with our international faculty, make BioEquity Europe a must-attend event for investors and business development and licensing professionals."

See the complete program, including presenting companies, plenary schedules and a list of the 2014 faculty at http://www.biocentury.com/conferences/bioequityeurope/dates/schedule.

The 2014 BioEquity Europe Presenting Companies
Presenting companies were screened using BioCentury's industry analysis and proprietary databases, including BioCentury's BCIQ online business intelligence platform. The result is an independently selected mix of companies with proven fundraising ability, prospects for key partnerships and proximity to potentially transformational milestones.

View the complete list of presenting companies and Next Wave Presenting Companies at http://www.biocentury.com/conferences/bioequityeurope/companies/presentingcompanies.

The BioEquity Europe Sponsors & Regional Host Committee
This unique turf-neutral setting is made possible by the support of the region's life science organizations and BioEquity Europe's Sponsors. The Regional Host Committee is comprised of Amsterdam BioMed Cluster/Amsterdam Economic Board, Axon, Deloitte and Van Campen Liem.

The prestigious group of 2014 sponsors is anchored by Gold Sponsors Ernst & Young, MS Ventures and Sofinnova Partners and Silver Sponsors Abingworth, AstraZeneca, Boehringer Ingelheim Venture Fund, Edwards Wildman, Geller Biopharm, Gilde Healthcare, Index Ventures, Inserm Transfert Initiative, Johnson & Johnson Innovation, LSP-Life Sciences Partners, Oxford Finance, Piper Jaffray and Roche Venture Fund.

About BioCentury
Since 1993, BioCentury Publications, Inc. has provided essential biopharma industry intelligence to a global audience of biotech and pharmaceutical executives, investors, regulators and public policy makers, and the scientific community. This audience has benefited from BioCentury's deep knowledge, data-driven analysis, independent perspective and trustworthy content available through the company's publications, television, data products and collaborative industry conferences in the U.S., Europe and Asia.

BioEquity Europe is one of three annual investor conferences organized by BioCentury. The next conference, NewsMakers in the Biotech Industry, will take place on Sept. 26, 2014, followed by Future Leaders in the Biotech Industry, on March 20, 2015. Both events will take place at the Millennium Broadway Hotel & Conference Center in New York City.

For more information, visit www.biocentury.com and www.biocenturytv.com.

About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group's conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™
  • Biotech Showcase™, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, co-produced with ChinaBio® LLC
  • EuroMedtech™
  • Partnering for Global Impact®

EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

About the Biotechnology Industry Organization
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
The 3rd International @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to th...
SYS-CON Media announced that Centrify, a provider of unified identity management across cloud, mobile and data center environments that delivers single sign-on (SSO) for users and a simplified identity infrastructure for IT, has launched an ad campaign on Cloud Computing Journal. The ads focus on security: how an organization can successfully control privilege for all of the organization’s identities to mitigate identity-related risk without slowing down the business, and how Centrify provides ...
The Internet of Things will greatly expand the opportunities for data collection and new business models driven off of that data. In her session at @ThingsExpo, Esmeralda Swartz, CMO of MetraTech, discussed how for this to be effective you not only need to have infrastructure and operational models capable of utilizing this new phenomenon, but increasingly service providers will need to convince a skeptical public to participate. Get ready to show them the money!
The 3rd International Internet of @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that its Call for Papers is now open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
The term culture has had a polarizing effect among DevOps supporters. Some propose that culture change is critical for success with DevOps, but are remiss to define culture. Some talk about a DevOps culture but then reference activities that could lead to culture change and there are those that talk about culture change as a set of behaviors that need to be adopted by those in IT. There is no question that businesses successful in adopting a DevOps mindset have seen departmental culture change, ...
In her General Session at 15th Cloud Expo, Anne Plese, Senior Consultant, Cloud Product Marketing, at Verizon Enterprise, focused on finding the right mix of renting vs. buying Oracle capacity to scale to meet business demands, and offer validated Oracle database TCO models for Oracle development and testing environments. Anne Plese is a marketing and technology enthusiast/realist with over 19+ years in high tech. At Verizon Enterprise, she focuses on driving growth for the Verizon Cloud platfo...
"There is a natural synchronization between the business models, the IoT is there to support ,” explained Brendan O'Brien, Co-founder and Chief Architect of Aria Systems, in this SYS-CON.tv interview at the 15th International Cloud Expo®, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Gridstore™, the leader in hyper-converged infrastructure purpose-built to optimize Microsoft workloads, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Gridstore™ is the leader in hyper-converged infrastructure purpose-built for Microsoft workloads and designed to accelerate applications in virtualized environments. Gridstore’s hyper-converged infrastructure is the ...
This builds on Puppet Labs' first class Windows support, including native .MSI packages for x32 and x64 operating systems, modules to extend common Windows server management tools, including Powershell, and integrations with Microsoft Azure and Visual Studio. By automating common Windows administration tasks, Puppet Labs is enabling users to adopt DevOps practices, thereby reducing the time needed to deploy applications from weeks to hours.
DevOps Summit 2015 New York, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is obsolete...
WebRTC defines no default signaling protocol, causing fragmentation between WebRTC silos. SIP and XMPP provide possibilities, but come with considerable complexity and are not designed for use in a web environment. In his session at @ThingsExpo, Matthew Hodgson, technical co-founder of the Matrix.org, discussed how Matrix is a new non-profit Open Source Project that defines both a new HTTP-based standard for VoIP & IM signaling and provides reference implementations.
There's Big Data, then there's really Big Data from the Internet of Things. IoT is evolving to include many data possibilities like new types of event, log and network data. The volumes are enormous, generating tens of billions of logs per day, which raise data challenges. Early IoT deployments are relying heavily on both the cloud and managed service providers to navigate these challenges. In her session at Big Data Expo®, Hannah Smalltree, Director at Treasure Data, discussed how IoT, Big D...
Connected devices and the Internet of Things are getting significant momentum in 2014. In his session at Internet of @ThingsExpo, Jim Hunter, Chief Scientist & Technology Evangelist at Greenwave Systems, examined three key elements that together will drive mass adoption of the IoT before the end of 2015. The first element is the recent advent of robust open source protocols (like AllJoyn and WebRTC) that facilitate M2M communication. The second is broad availability of flexible, cost-effective ...
Scott Jenson leads a project called The Physical Web within the Chrome team at Google. Project members are working to take the scalability and openness of the web and use it to talk to the exponentially exploding range of smart devices. Nearly every company today working on the IoT comes up with the same basic solution: use my server and you'll be fine. But if we really believe there will be trillions of these devices, that just can't scale. We need a system that is open a scalable and by using ...
"SAP had made a big transition into the cloud as we believe it has significant value for our customers, drives innovation and is easy to consume. When you look at the SAP portfolio, SAP HANA is the underlying platform and it powers all of our platforms and all of our analytics," explained Thorsten Leiduck, VP ISVs & Digital Commerce at SAP, in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.